Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation

J Immunol. 2005 Nov 1;175(9):6143-54. doi: 10.4049/jimmunol.175.9.6143.

Abstract

Foci of autoantigen-specific B lymphocytes in nonlymphoid tissues have been associated with development of autoimmune disease. To better understand the genesis of such ectopic lymphoid tissue, this study investigated whether several B cell-tropic innate immune system molecules, known to be elevated in response to inflammatory stimuli, can cooperate in fostering the T cell-independent clonal expansion of mature human B2 cells under conditions of limiting BCR engagement. Notable synergy was observed between BCR coligation with the C3dg-binding CD21/CD19 costimulatory complex, B cell-activating factor belonging to the TNF family (BAFF), and IL-4 in generating B cell progeny with sustained CD86 and DR expression. The synergy was observed over a wide range of BCR:ligand affinities and involved: 1) cooperative effects at promoting early cell cycle progression and viability; 2) BCR:CD21 coligation-promoted increases in BAFF receptors that were highly regulated by IL-4; 3) reciprocal effects of IL-4 and BAFF at dampening daughter cell apoptosis typical of stimulation by BCR:CD21 and either cytokine alone; and 4) BAFF-sustained expression of antiapoptotic Mcl-1 within replicating lymphoblasts. The results suggest that significant clonal proliferation of recirculating B2 cells occurs upon limited binding to C3dg-coated Ag in an inflammatory in vivo milieu containing both BAFF and IL-4. When rare autoantigen-presenting B cells undergo such expansions, both B cell and T cell autoimmunity may be promoted.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Antibodies, Anti-Idiotypic / pharmacology
  • Antigens, CD19 / physiology
  • B-Cell Activating Factor
  • B-Lymphocyte Subsets / immunology
  • B-Lymphocyte Subsets / physiology*
  • Cell Survival
  • Child
  • Child, Preschool
  • Histocompatibility Antigens Class II / analysis
  • Humans
  • Immunity, Innate*
  • Interleukin-4 / pharmacology
  • Lymphocyte Activation
  • Membrane Proteins / pharmacology
  • Membrane Proteins / physiology
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins / analysis
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Receptors, Antigen, B-Cell / physiology
  • Receptors, Complement 3d / physiology
  • Receptors, Tumor Necrosis Factor / physiology
  • S Phase
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antibodies, Anti-Idiotypic
  • Antigens, CD19
  • B-Cell Activating Factor
  • Histocompatibility Antigens Class II
  • Membrane Proteins
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Antigen, B-Cell
  • Receptors, Complement 3d
  • Receptors, Tumor Necrosis Factor
  • TNFRSF13B protein, human
  • TNFSF13B protein, human
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor-alpha
  • anti-IgM
  • Interleukin-4